Status:
COMPLETED
Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Stand Up To Cancer
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this research is to study an intervention, which the investigators call "Supportive Oncology Care at Home," that entails both remote patient monitoring (e.g. patient-reported symptoms, hom...
Detailed Description
Preoperative treatment can cause significant morbidity and often result in hospitalizations. Patients receiving preoperative FOLFIRINOX often experience numerous side effects, including nausea, vomiti...
Eligibility Criteria
Inclusion
- Age 18 or older
- Within three weeks of signing consent for parent trial of neoadjuvant FOLFIRINOX
- Planning to receive care at Massachusetts General Hospital
- Ability to read and respond to questions in English
- Residing within 50 miles of Massachusetts General Hospital
Exclusion
- Uncontrolled psychiatric illness or impaired cognition
Key Trial Info
Start Date :
January 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03798769
Start Date
January 31 2019
End Date
September 1 2022
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryan Nipp
Boston, Massachusetts, United States, 02114